NoMy
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NoMy - overview
Established
2020
Location
Oslo, -, Norway
Primary Industry
Food
About
Based in Oslo, Norway, and founded in 2020 by CEO Ingrid Dynna and David Andrew Quist, Norwegian Mycelium AS, d. b. a. NoMy, operates as a food company that focuses on developing sustainable foods and materials from fungi, including meat alternatives and bio-composites, using local resources and fermentation science.
In May 2025, NoMy raised EUR 1. 25 million in venture funding led by new investor Nippon Beet Sugar Manufacturing Co. , Ltd. Returning investors TD Veen, EIT Food, Farvatn Venture, and other unspecified investors also participated in the round.
NoMy is creating a variety of food ingredients, including new meat alternatives, new bio-composites, and new protein sources from mycelium, which is the root-like filaments of fungi. The company also provides alternative protein solutions for aquaculture by converting local food industry by-products into feed ingredients. This process offers a sustainable option compared to traditional fish feeds, which often rely on imported agricultural commodities. The company plans to utilize the May 2025 funding to enhance the implementation of its mycoprotein technologies.
Current Investors
Firda, StartupLab , TD Veen
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Biotechnology
Website
www.nomy.no
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.